Výsledky vyhledávání - "Fahrettin Covut"

Akademický článek

Evaluation of the United Kingdom‐primary biliary cholangitis and global primary biliary cholangitis group prognostic models for primary biliary cholangitis patients treated with ursodeoxycholic acid in the U.S. population

Autor: Mohammad Alomari, Fahrettin Covut, Laith Al Momani, Pravallika Chadalavada, Asif Hitawala, Mark F Young, Carlos Romero‐Marrero

Publikováno v: JGH Open, Vol 4, Iss 2, Pp 132-139 (2020)

Background and Aim The United Kingdom‐primary biliary cholangitis (UK‐PBC) and global primary biliary cholangitis group (GLOBE) prognostic models have been recently developed to predict long‐term outcomes in primary biliary cholangitis (PBC). H

Externí odkaz: https://doaj.org/article/05f9830a13204450bffe137504f730dd

Zobrazit plný text záznamu

Akademický článek

Tocilizumab for treatment of patients with severe COVID–19: A retrospective cohort study

Autor: Tariq Kewan, Fahrettin Covut, Mohammed J. Al–Jaghbeer, Lori Rose, K.V. Gopalakrishna, Bassel Akbik

Publikováno v: EClinicalMedicine, Vol 24, Iss , Pp 100418- (2020)

Background: Tocilizumab was approved for chimeric antigen receptor T–cell therapy induced cytokine release syndrome and it may provide clinical benefit for selected COVID–19 patients. Methods: In this retrospective cohort study, we analyzed hypox

Externí odkaz: https://doaj.org/article/6a51083dbd6d404583e3f51f1179695b

Zobrazit plný text záznamu

Bispecific Antibodies for the Treatment of Multiple Myeloma

Autor: Scott R. Goldsmith, Shawn Streeter, Fahrettin Covut

Publikováno v: Current Hematologic Malignancy Reports. 17:286-297

Advances in multiple myeloma therapies have greatly improved outcomes for patients living with the disease, although to date there is yet to be a cure. Cellular and immunotherapies, approved or in development, offer the promise of significantly advan

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::835dfce1dfed7b84ac3921f74756581d
https://doi.org/10.1007/s11899-022-00675-3

Zobrazit plný text záznamu

Etiology of and predictive factors for chronic intestinal failure requiring long term parenteral support in the last two decades: A retrospective study

Autor: Fahrettin Covut, Laith Al Momani, Mohammad Alomari, May Olayan, Hunter Bratton, Mark Young, Pravallika Chadalavada

Publikováno v: Clinical Nutrition ESPEN. 37:168-172

Chronic intestinal failure (CIF) has been long-recognized, however the underlying etiology and risk factors have not been historically well-studied. We aim to study the underlying etiologies of CIF and predictive factors for long-term parenteral supp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f5097ce82d2ada1cf4f0de7e9b43eaf
https://doi.org/10.1016/j.clnesp.2020.02.019

Zobrazit plný text záznamu

Gastrointestinal Toxicities of Immune Checkpoint Inhibitors Are Associated With Enhanced Tumor Responsiveness and Improved Survival

Autor: Mohammad Alomari, Suleiman Al Ashi, Pravallika Chadalavada, Shrouq Khazaaleh, Fahrettin Covut, Laith Al Momani, Ahmed Elkafrawy, Vinay Padbidri, Pauline Funchain, Donald Campbell, Carlos Romero-Marrero

Publikováno v: Gastroenterology research. 15(2)

Immune checkpoint inhibitors (ICIs) are increasingly used to treat advanced malignancies. However, they are associated with the development of multiple gastrointestinal immune-related adverse events (GI-irAEs). We aimed to evaluate the types and seve

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85ed239606d6c42023eef68213bc6b6d
https://pubmed.ncbi.nlm.nih.gov/35572476

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání